BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10589910)

  • 21. An atypical course of visceral leishmaniasis (Kala-azar) in a liver transplant recipient.
    Clemente WT; Couto CA; Ribeiro DD; de Medeiros Chaves França M; Sanches MD
    Transplantation; 2007 Feb; 83(3):368-9. PubMed ID: 17297421
    [No Abstract]   [Full Text] [Related]  

  • 22. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
    Ramesh V
    Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil.
    Lima Verde FA; Lima Verde FA; Lima Verde IA; Silva Junior GB; Daher EF; Lima Verde EM
    J Nephrol; 2007; 20(4):430-6. PubMed ID: 17879209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An unusual presentation of post-kala-azar dermal leishmaniasis.
    Ramesh V; Kumar J; Salotra P
    Trop Doct; 2007 Jul; 37(3):172-3. PubMed ID: 17716510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-kala-azar dermal leishmaniasis as an immune reconstitution inflammatory syndrome in a patient with acquired immune deficiency syndrome.
    Antinori S; Longhi E; Bestetti G; Piolini R; Acquaviva V; Foschi A; Trovati S; Parravicini C; Corbellino M; Meroni L
    Br J Dermatol; 2007 Nov; 157(5):1032-6. PubMed ID: 17854365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kala azar in an adult Libyan and review of visceral leishmaniasis in Libya.
    Jain S; el Mangoush MA; el-Bouri K; Mahfouz MO
    Trop Geogr Med; 1990 Jul; 42(3):283-5. PubMed ID: 2293439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visceral leishmaniasis after orthotopic liver transplantation: a rare cause of infection.
    Pereira CM; Oliveira HM; Lopes V; Gandara J; Ferreira S; Daniel J; Miranda HP
    Transpl Infect Dis; 2016 Apr; 18(2):251-4. PubMed ID: 26895697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Childhood kala-azar: the cases of a decade].
    López Peña LF; Clemente Yago F; de la Cruz Amorós F; Gorostiza Felipe P; Monferrer Fábregat R; Escrivá Tomás P
    An Esp Pediatr; 1993 Sep; 39(3):199-201. PubMed ID: 8250431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: a retrospective multicenter case-control study.
    Clemente W; Vidal E; Girão E; Ramos AS; Govedic F; Merino E; Muñoz P; Sabé N; Cervera C; Cota GF; Cordero E; Mena A; Montejo M; López-Medrano F; Aguado JM; Fernandes P; Valerio M; Carratalá J; Moreno A; Oliveira J; Mourão PH; Torre-Cisneros J
    Clin Microbiol Infect; 2015 Jan; 21(1):89-95. PubMed ID: 25636932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visceral leishmaniasis in Israel, 1960-2000.
    Ya'ari A; Jaffe CL; Garty BZ
    Isr Med Assoc J; 2004 Apr; 6(4):205-8. PubMed ID: 15115257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Leishmaniasis (kala-azar, oriental sore, South American leishmaniasis)].
    Malamos B
    Wien Z Inn Med; 1967; 48(6):209-21. PubMed ID: 5630155
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiological, clinical and therapeutic features of pediatric kala-azar.
    Rahim KM; Ashkan MM
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):626-30. PubMed ID: 17882998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
    Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
    Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and outcomes of cytomegalovirus retinitis after transplantation.
    Eid AJ; Bakri SJ; Kijpittayarit S; Razonable RR
    Transpl Infect Dis; 2008 Feb; 10(1):13-8. PubMed ID: 17511815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on patients with kala-azar treated at the Hospital for Infectious Diseases in Zagreb].
    Falisevac J; Bacun-Kubović M
    Lijec Vjesn; 1973; 95(3):122-6. PubMed ID: 4701189
    [No Abstract]   [Full Text] [Related]  

  • 39. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
    Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
    Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kala-azar in the adult. Apropos of 11 cases].
    Aguado Garciá JM; Fernández Guerrero ML; Arnal P; Díaz Fernández JL; Gómez Huelgas R; Diáz Curiel M; Marín Hernández G; De Villalobos E; Sánchez Fayos J
    Rev Clin Esp; 1983 Oct; 171(2):119-23. PubMed ID: 6658090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.